Copelink Blog

Triple negative breast cancer (TNBC) is a breast cancer subtype, which is found in 10-20% of all breast cancer diagnoses each year. The name originates from tumors found in the breast that are estrogen receptor-negative, progesterone receptor-negative, and human epidermal growth factor receptor 2-negative. In other words, TNBC tumors do not exhibit any of these three receptors. Although these tumors do not respond to receptor-specific treatments, they are typically responsive to chemotherapy.

We’re excited to announce that we’ve joined Merck on the Your Cancer Game Plan Challenge, a social sharing program that will help us raise funds and continue our support of cancer patients, caregivers, healthcare providers and others

CancerCare is grateful for our partnership with Hines Property Management. The New York City office of the global real estate company recently donated funds and teddy bears to CancerCare during the holiday season.

For the fifth consecutive year, Caribou Coffee partnered with CancerCare, donating 10% of all October coffee bean sales and Amy’s merchandise proceeds to CancerCare.

CancerCare recently partnered with Sephora to bring a Brave Beauty in the Face of Cancer class to our clients.

Now through October 31, 2017, Caribou Coffee will donate 10 percent of Amy’s Blend purchases to CancerCare.

Triple Negative Breast Cancer Day is the only global event dedicated to raising both awareness and funds exclusively for women coping with triple negative breast cancer.

Cancer survivors, caregivers, patient advocates, family physicians, oncology providers, and others gathered at “An Evening for Cancer Survivors and Caregivers” to make connections, discuss survivorship issues, and get expert answers on their survivorship-related questions.

For more than 30 years, October has been recognized as Breast Cancer Awareness Month, with the goal of increasing awareness and raising funds to support research.

The CancerCare LegalHealth Clinic is available to cancer patients and caregivers living in New York City’s five boroughs who are seeking legal advice on an issue related to a cancer diagnosis.